Abstract:Background: It is common to see patients who need orthodontic treatment but with insufficient alveolar bone volume. However, safe and effective tooth movement requires sufficient alveolar bone width and height. The aim of this study is to compare the bone augmentation efficacy of Autologous Partially Demineralized Dentin Matrix (APDDM) and Deproteinized Bovine Bone Mineral (DBBM) in orthodontic patients with insufficient bone by using a randomized controlled clinical trial approach. Materials and methods: Twenty-seven orthodontic patients involving 40 posterior teeth alveolar sites (n = 40) with insufficient alveolar bone volume were randomly divided into a control group (n = 20) and an experimental group (n = 20). The patients in the experimental group were treated with APDDM, and those in the control group were treated with DBBM. After surgery, the adjacent teeth are moved toward the bone grafting sites according to the orthodontic treatment plan. Patients completed a postoperative response questionnaire by the Visual Analogue Scale (VAS) score to indicate pain and swelling in the bone grafted area at the time of suture removal; and CBCT scans were conducted before surgery, 6 months and 2 years after surgery to assess changes in buccal and central alveolar heights, as well as widths at the alveolar ridge apex and 3 mm, 5 mm below the apex, respectively. The CBCT image sequences were imported into Mimics 21.0 software in DICOM format. The data of the patients in both groups were collected and analyzed by SPSS 25.0. Results: The VAS scores were significantly lower in the APDDM group than in the DBBM group (p < 0.05). Significant increases were observed in alveolar bone height and width at 6 months and 2 years postoperative (p < 0.05); At 2 years, the APDDM group exhibited a reduction in buccal crest height and in 3 mm, 5 mm width below alveolar ridge apex, relative to 6 months (p < 0.05), while the DBBM group showed a decrease only in the central height of the alveolar bone (p < 0.05). There was a significant bone augmentation increase found only 3 mm below the alveolar ridge apex in the APDDM group compared with the DBBM group among all 6 months group comparison (p < 0.05). At 2 years, the augmentation effects were similar across both groups (p > 0.05). Conclusion: Radiomics analysis indicates that APDDM serves as a viable bone augmentation material for orthodontic patients with insufficient alveolar bone volume, achieving comparable clinical efficacy to DBBM. Additionally, APDDM is associated with a milder postoperative response than DBBM. The registration number (trn): ChiCTR2400084607.

Osteogenic Potential of Recombinant Human Bone Morphogenetic Protein ⁃ 2 Combined with Bio ⁃ Oss Bone Substitute in Implant Restorations in Anterior Esthetic Region

Bone Formation at Porous Titanium Implants Coated with Multiple Layers of Recombinant Human Bone Morphogenetic Protein-2 Cdna Plasmid in the Posterior Mandible in Dogs.

Recombinant Human Bone Morphogenic Protein-2 Combined With Autogenous Bone Graft for Reconstruction of Alveolar Cleft

Microcomputed tomographic and histologic analysis of anorganic bone matrix coupled with cell-binding peptide suspended in sodium hyaluronate carrier after sinus augmentation: a clinical study

Reconstruction of Mandibular Bone Defects Using Biphasic Calcium Phosphate Bone Substitutes with Simultaneous Implant Placement in Mini-Swine: A Pilot in Vivo Study.

Radiographic and Histological Evaluation of Bone Formation Induced by Rhbmp-2-incorporated Biomimetic Calcium Phosphate Material in Clinical Alveolar Sockets Preservation.

Clinical Efficacy of Mineralized Collagen (MC) Versus Anorganic Bovine Bone (Bio-Oss) for Immediate Implant Placement in Esthetic Area: a Single-Center Retrospective Study

Autogenous bone ring augmentation around single tooth implantation in the esthetic zone: A retrospective case series study with 2–3 years of follow-up

Effect of Autologous Concentrated Growth Factor Fibrin Solution Combined with Bio-Oss Bone Powder on Mucosal Healing and Bone Regeneration after Oral Implanted Guided Bone Regeneration

Implant-guided supracrestal alveolar bone growth using scaffolds, BMP-2, and novel scaffold-retaining device

Histological and Immunohistochemical Evaluation of Rh-BMP2: Effect on Gingival Healing Acceleration and Proliferation of Human Epithelial Cells

Osseointegration Potential Assessment of Bone Graft Materials Loaded with Mesenchymal Stem Cells in Peri-Implant Bone Defects

Effect of rhBMP-2 Immobilized Anorganic Bovine Bone Matrix on Bone Regeneration

Efficacy of Bacterial Cellulose as a Carrier of BMP-2 for Bone Regeneration in a Rabbit Frontal Sinus Model

Engineering of Bone Using Rhbmp-2-Loaded Mesoporous Silica Bioglass and Bone Marrow Stromal Cells for Oromaxillofacial Bone Regeneration

[Clinical study of titanium mesh in conjunction with concentrate growth factors to rebuild severe bone defect of anterior maxilla]

Reconstruction of Peri-Implant Bone Defects Using Impacted Bone Allograft and BMP-2 Gene-Modified Bone Marrow Stromal Cells.

Comparison of clinical efficacy between autologous partially demineralized dentin matrix and deproteinized bovine bone mineral for bone augmentation in orthodontic patients with alveolar bone deficiency: a randomized controlled clinical trial

Peri‐Implant Bone Regeneration Using Rhpdgf‐bb, BMSCs, and Β‐tcp in a Canine Model

Functionalised High-Performance Oxide Ceramics with Bone Morphogenic Protein 2 (BMP-2) Induced Ossification: An In Vivo Study

Esthetic Outcome of Guided Bone Regeneration with Titanium Membrane in Single Anterior Maxillary Implant Site